Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyTue, 16 Jul 2024 10:34:12 +0200Mon, 01 Jul 2024 16:05:00 +0200Human medicines European public assessment report (EPAR): Agilus, dantrolene sodium, hemiheptahydrate, Date of authorisation: 29/05/2024, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/agilusHuman medicines European public assessment report (EPAR): Agilus, dantrolene sodium, hemiheptahydrate, Date of authorisation: 29/05/2024, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/agilusMon, 01 Jul 2024 16:05:00 +0200Human medicineAgilus : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/emea-combined-h-6009-en.pdfAgilus : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/emea-combined-h-6009-en.pdfMon, 01 Jul 2024 15:01:00 +0200Human medicine